Human Parainfluenza Virus Type Infection

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-04-16
Clinical Trial Update: Study of the Infectivity, Safety and Immunogenicity of Two Recombinant, Live-Attenuated, B/HPIV3 Vectored Vaccines Expressing the Fusion Glycoprotein of HMPV Delivered by Nasal Spray to HPIV3-Seropositive Children 24 to <60 Months of Age [Phase 1]
Phase 1 trial evaluating infectivity, safety, and immunogenicity of two recombinant, live-attenuated B/HPIV3 vectored vaccines expressing th…